China launches Sanofi probe following bribery allegations
This article was originally published in Scrip
Authorities in Beijing have begun a formal investigation into Sanofi after a Chinese newspaper reported details of alleged payments by the French pharma giant to more than 500 doctors in the country in 2007.
You may also be interested in...
Japan approves a batch of new products and indications, including Daiichi Sankyo's Enhertu in a high-need indication after a rapid review and Takeda's Zejula, which will be made available to selected patients before its reimbursement listing.
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.
Japanese ophthalmic specialist picks up young private US firm and gains a small but broad set of marketed products.